Literature DB >> 24613139

In vitro study of thimerosal reactions in human whole blood and plasma surrogate samples.

Stefan Trümpler1, Björn Meermann2, Sascha Nowak1, Wolfgang Buscher1, Uwe Karst1, Michael Sperling3.   

Abstract

Because of its bactericidal and fungicidal properties, thimerosal is used as a preservative in drugs and vaccines and is thus deliberately injected into the human body. In aqueous environment, it decomposes into thiosalicylic acid and the ethylmercury cation. This organomercury fragment is a potent neurotoxin and is suspected to have similar toxicity and bioavailability like the methylmercury cation. In this work, human whole blood and physiological simulation solutions were incubated with thimerosal to investigate its behaviour and binding partners in the blood stream. Inductively coupled plasma with optical emission spectrometry (ICP-OES) was used for total mercury determination in different blood fractions, while liquid chromatography (LC) coupled to electrospray ionisation time-of-flight (ESI-TOF) and inductively coupled plasma-mass spectrometry (ICP-MS) provided information on the individual mercury species in plasma surrogate samples. Analogous behaviour of methylmercury and ethylmercury species in human blood was shown and an ethylmercury-glutathione adduct was identified.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Ethylmercury; Human w; Hyphenated; Speciation; Thimerosal; analysis; hole b; lood; techniques

Mesh:

Substances:

Year:  2014        PMID: 24613139     DOI: 10.1016/j.jtemb.2014.01.006

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  6 in total

1.  Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study.

Authors:  Mario Suwalsky; Pablo Zambrano; María José Gallardo; Fernando Villena; Malgorzata Jemiola-Rzeminska; Kazimierz Strzalka
Journal:  J Membr Biol       Date:  2016-10-13       Impact factor: 1.843

2.  A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.

Authors:  David A Geier; Janet K Kern; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  Biol Trace Elem Res       Date:  2014-11-11       Impact factor: 3.738

3.  Effects on and transfer across the blood-brain barrier in vitro-Comparison of organic and inorganic mercury species.

Authors:  Hanna Lohren; Julia Bornhorst; Romy Fitkau; Gabriele Pohl; Hans-Joachim Galla; Tanja Schwerdtle
Journal:  BMC Pharmacol Toxicol       Date:  2016-12-15       Impact factor: 2.483

4.  A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs.

Authors:  David A Geier; Janet K Kern; Brian S Hooker; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  J Epidemiol Glob Health       Date:  2015-07-09

5.  Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine.

Authors:  Kawaljit Kaur; Jian Xiong; Nishant Sawant; Sanjeev Agarwal; John M Hickey; David A Holland; Tarit K Mukhopadhyay; Joseph R Brady; Neil C Dalvie; Mary Kate Tracey; Kerry R Love; J Christopher Love; David D Weis; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2020-12-03       Impact factor: 3.534

6.  A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.

Authors:  David A Geier; Brian S Hooker; Janet K Kern; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  Int J Environ Res Public Health       Date:  2014-09-05       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.